Geometry Dash APK Hill Climb Racing APK
65.5 F
New York
Saturday, September 30, 2023

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) is Holding Steady

Must read

The Ironwood Pharmaceuticals Inc. (IRWD) shares are trading at lower $9.51 and the avg recommendation for the stock is Moderate Buy. while the current analyst price target stands at $12.20.

To add more color to this target, the company’s high over the last year is $14.10 and the low is $7.91. Over the last 52 weeks, IRWD is down -32.55% while the S&P 500 is down -0.64%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, IRWD reported a profit of $77.7 million. Ironwood Pharmaceuticals Inc. also saw revenues increase to $79.94 million. In addition, IRWD has free cash flow of $42.16 million as of 03-2020. The company’s EBITDA came in at $13.91 million which compares well with its peers.

IRWD booked profit margins of 19.10%, its Return on Equity (ROE) is -62.60%, and its Return on Assets is 23.10%. All told, it is clear that, IRWD needs to be on your watchlist.

Find out when IRWD reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. IRWD has a short ratio of 11.78 and outstanding shares of 158.37M.

Company Outlook

IRWD has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 2.11 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at 0.54. Ironwood Pharmaceuticals Inc. IRWD also noted assets of $404.0 million at the end of the last quarter. Investors should also keep an eye on sector updates as IRWD has historically followed its peers on positive news.

All told, Ironwood Pharmaceuticals Inc. IRWD has strung together solid data and demonstrated underlying fundamentals. At its current valuation, IRWD represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Ironwood Pharmaceuticals Inc. IRWD is now commanding a market cap of 1.56B and a float of 154.70M. IRWD is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of IRWD stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in IRWD, either long or short, and we have not been compensated for this article.

Latest article